SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-294451
Filing Date
2022-11-29
Accepted
2022-11-29 17:18:36
Documents
13
Period of Report
2022-11-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d383364d8k.htm   iXBRL 8-K 23533
  Complete submission text file 0001193125-22-294451.txt   175757

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20221123.xsd EX-101.SCH 3328
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20221123_def.xml EX-101.DEF 13555
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20221123_lab.xml EX-101.LAB 22570
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20221123_pre.xml EX-101.PRE 14375
7 EXTRACTED XBRL INSTANCE DOCUMENT d383364d8k_htm.xml XML 3669
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 221433658
SIC: 2833 Medicinal Chemicals & Botanical Products